Epidemiology, Microbiology and Diagnosis of Helicobacter Pylori
Referanslar
Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clinical microbiology reviews. 1997;10(4):720-741. doi: 10.1128/CMR.10.4.720.
Parkin DM. International variation. Oncogene. 2004;23(38):6329-6340. doi: 10.1038/sj.onc.1207726.
Peleteiro B, Bastos A, Ferro A, et al. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Digestive diseases and sciences. 2014;59(8):1698-1709. doi: 10.1007/s10620-014-3063-0.
Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. 2017;20(Suppl 1):3-7. doi: 10.1007/s10120-016-0658-5.
Krueger WS, Hilborn ED, Converse RR, et al. Environmental risk factors associated with Helicobacter pylori seroprevalence in the United States: a cross-sectional analysis of NHANES data. Epidemiology and Infection. 2015;143(12):2520-2531. doi: 10.1017/S0950268814003938.
Fox JG. Non-human reservoirs of Helicobacter pylori. Alimentary pharmacology & therapeutics. 1995;9 Suppl 2:93-103.
Thomas JE, Gibson GR, Darboe MK, et al. Isolation of Helicobacter pylori from human faeces. Lancet. 1992;340(8829):1194-1195. doi: 10.1016/0140-6736(92)92894-l.
Queralt N, Bartolomé R, Araujo R. Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north-east of Spain. Journal of applied microbiology. 2005;98(4):889-895. doi: 10.1111/j.1365-2672.2004.02523.x.
Aziz RK, Khalifa MM, Sharaf RR. Contaminated water as a source of Helicobacter pylori infection: A review. Journal of advanced research. 2015;6(4):539-547. doi: 10.1016/j.jare.2013.07.007.
Hachem CY, Clarridge JE, Evans DG, et al. Comparison of agar based media for primary isolation of Helicobacter pylori. Journal of clinical pathology. 1995;48(8):714-716. doi: 10.1136/jcp.48.8.714.
Han SW, Flamm R, Hachem CY, et al. Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. European journal of clinical microbiology & infectious diseases. 1995;14(4):349-352. doi: 10.1007/BF02116531.
Gu H. Role of Flagella in the Pathogenesis of Helicobacter pylori. Current microbiology.. 2017;74(7):863-869. doi: 10.1007/s00284-017-1256-4.
Harris PR, Mobley HL, Perez-Perez Gıet al. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology. 1996;111(2):419-425. doi: 10.1053/gast.1996.v111.pm8690207.
Suerbaum S, Thiberge JM, Kansau I, et al. Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity. Molecular microbiology. 1994;14(5):959-974. doi: 10.1111/j.1365-2958.1994.tb01331.x.
Ishijima N, Suzuki M, Ashida H et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. The Journal of biological chemistry. 2011;286(28):25256-25264. doi: 10.1074/jbc.M111.233601.
Toller IM, Neelsen KJ, Steger M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(36):14944-14949. doi: 10.1073/pnas.1100959108.
Kist M, Spiegelhalder C, Moriki T, et al. Interaction of Helicobacter pylori (strain 151) and Campylobacter coli with human peripheral polymorphonuclear granulocytes Zentralblatt fur Bakteriologie : international journal of medical microbiology. 1993 ;280(1-2):58-72. doi: 10.1016/s0934-8840(11)80941-2.
Eaton KA, Catrenich CE, Makin KM, et al. Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets. The Journal of infectious diseases. 1995;171(2):459-462. doi: 10.1093/infdis/171.2.459.
Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(25):14648-14653. doi: 10.1073/pnas.93.25.14648.
Suzuki M, Mimuro H, Kiga K, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell host & microbe. 2009;5(1):23-34. doi: 10.1016/j.chom.2008.11.010..
Suzuki N, Murata-Kamiya N, Yanagiya K, et al. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein. Scientific reports. 2015;5:10024. doi: 10.1038/srep10024.
Sobhani I, Bado A, Cherifi Y, et al. Helicobacter pylori stimulates gastric acid secretion via platelet activating factor. Journal of physiology and pharmacology. 1996;47(1):177-185.
Piotrowski J, Slomiany A, Slomiany BL. Inhibition of Helicobacter pylori urease activity by ebrotidine. Biochemistry and molecular biology international. 1995;37(2):247-253.
Mauch F, Bode G, Ditschuneit H, et al. Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology. 1993;105(6):1698-1704. doi: 10.1016/0016-5085(93)91065-p.
Smith AW, Chahal B, French GL. The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Molecular Microbiology. 1994;13(1):153-160. doi: 10.1111/j.1365-2958.1994.tb00410.x.
Cover TL, Halter SA, et al. Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. Human pathology. 1992;23(9):1004-1010. doi: 10.1016/0046-8177(92)90261-z.
Czajkowsky DM, Iwamoto H, Cover TL, et al. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH Proceedings of the National Academy of Sciences of the United States of America. 1999;96(5):2001-2006. doi: 10.1073/pnas.96.5.2001
Gangwer KA, Shaffer CL, Suerbaum Set al. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. Journal of bacteriology. 2010;192(23):6126-6135. doi: 10.1128/JB.01081-10.
Cover TL. Helicobacter pylori Diversity and Gastric Cancer Risk. mBio. 2016 ;7(1):e01869-186915. doi: 10.1128/mBio.01869-15.
Davies GR, Banatvala N, Collins CE, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scandinavian journal of gastroenterology. 199;29(5):419-424. doi: 10.3109/00365529409096832.
Gisbert JP, Pajares JM. Helicobacter pylori test-and-treat' strategy for dyspeptic patients. Scandinavian journal of gastroenterology. 1999;34(7):644-652. doi: 10.1080/003655299750025822.
Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. The American journal of gastroenterology. 1998;93(12):2330-2338. doi: 10.1111/j.1572-0241.1998.00684.x.
Kelly SM, Pitcher MC, Farmery SM, et al. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology. 1994;107(6):1671-1674. doi: 10.1016/0016-5085(94)90806-0.
Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. The American journal of gastroenterology. 2006;101(8):1921-30. doi: 10.1111/j.1572-0241.2006.00668.x.
Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61(5):646-664. doi: 10.1136/gutjnl-2012-302084.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365-388. doi: 10.1055/a-0859-1883.
Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointestinal endoscopy, 1994;40(3):342-345. doi: 10.1016/s0016-5107(94)70067-2.
Craanen ME, Dekker W, Blok P, et al. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992;33(1):16-20. doi: 10.1136/gut.33.1.16.
Price AB. The Sydney System: histological division. Journal of gastroenterology and hepatology. 1991;6(3):209-222. doi: 10.1111/j.1440-1746.1991.tb01468.x.
Torun C, Yavuz A, Akan K, et al. Comparison of the diagnostic accuracy of the updated Sydney system and single biopsy. Saudi Journal of Gastroenterology. 2022;28(6):441-447. doi: 10.4103/sjg.sjg_146_22.
Gatta L, Vakil N, Ricci C, et al. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. The American journal of gastroenterology. 2004 ;99(5):823-829. doi: 10.1111/j.1572-0241.2004.30162.x.
Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical microbiology reviews. 2007;20(2):280-322. doi: 10.1128/CMR.00033-06.
Osato MS, Reddy R, Reddy SG, et al. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Archives of internal medicine. 2001;161(9):1217-1220. doi: 10.1001/archinte.161.9.1217.
Parkin DM. International variation. Oncogene. 2004;23(38):6329-6340. doi: 10.1038/sj.onc.1207726.
Peleteiro B, Bastos A, Ferro A, et al. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Digestive diseases and sciences. 2014;59(8):1698-1709. doi: 10.1007/s10620-014-3063-0.
Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. 2017;20(Suppl 1):3-7. doi: 10.1007/s10120-016-0658-5.
Krueger WS, Hilborn ED, Converse RR, et al. Environmental risk factors associated with Helicobacter pylori seroprevalence in the United States: a cross-sectional analysis of NHANES data. Epidemiology and Infection. 2015;143(12):2520-2531. doi: 10.1017/S0950268814003938.
Fox JG. Non-human reservoirs of Helicobacter pylori. Alimentary pharmacology & therapeutics. 1995;9 Suppl 2:93-103.
Thomas JE, Gibson GR, Darboe MK, et al. Isolation of Helicobacter pylori from human faeces. Lancet. 1992;340(8829):1194-1195. doi: 10.1016/0140-6736(92)92894-l.
Queralt N, Bartolomé R, Araujo R. Detection of Helicobacter pylori DNA in human faeces and water with different levels of faecal pollution in the north-east of Spain. Journal of applied microbiology. 2005;98(4):889-895. doi: 10.1111/j.1365-2672.2004.02523.x.
Aziz RK, Khalifa MM, Sharaf RR. Contaminated water as a source of Helicobacter pylori infection: A review. Journal of advanced research. 2015;6(4):539-547. doi: 10.1016/j.jare.2013.07.007.
Hachem CY, Clarridge JE, Evans DG, et al. Comparison of agar based media for primary isolation of Helicobacter pylori. Journal of clinical pathology. 1995;48(8):714-716. doi: 10.1136/jcp.48.8.714.
Han SW, Flamm R, Hachem CY, et al. Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. European journal of clinical microbiology & infectious diseases. 1995;14(4):349-352. doi: 10.1007/BF02116531.
Gu H. Role of Flagella in the Pathogenesis of Helicobacter pylori. Current microbiology.. 2017;74(7):863-869. doi: 10.1007/s00284-017-1256-4.
Harris PR, Mobley HL, Perez-Perez Gıet al. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology. 1996;111(2):419-425. doi: 10.1053/gast.1996.v111.pm8690207.
Suerbaum S, Thiberge JM, Kansau I, et al. Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity. Molecular microbiology. 1994;14(5):959-974. doi: 10.1111/j.1365-2958.1994.tb01331.x.
Ishijima N, Suzuki M, Ashida H et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. The Journal of biological chemistry. 2011;286(28):25256-25264. doi: 10.1074/jbc.M111.233601.
Toller IM, Neelsen KJ, Steger M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(36):14944-14949. doi: 10.1073/pnas.1100959108.
Kist M, Spiegelhalder C, Moriki T, et al. Interaction of Helicobacter pylori (strain 151) and Campylobacter coli with human peripheral polymorphonuclear granulocytes Zentralblatt fur Bakteriologie : international journal of medical microbiology. 1993 ;280(1-2):58-72. doi: 10.1016/s0934-8840(11)80941-2.
Eaton KA, Catrenich CE, Makin KM, et al. Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets. The Journal of infectious diseases. 1995;171(2):459-462. doi: 10.1093/infdis/171.2.459.
Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(25):14648-14653. doi: 10.1073/pnas.93.25.14648.
Suzuki M, Mimuro H, Kiga K, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell host & microbe. 2009;5(1):23-34. doi: 10.1016/j.chom.2008.11.010..
Suzuki N, Murata-Kamiya N, Yanagiya K, et al. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein. Scientific reports. 2015;5:10024. doi: 10.1038/srep10024.
Sobhani I, Bado A, Cherifi Y, et al. Helicobacter pylori stimulates gastric acid secretion via platelet activating factor. Journal of physiology and pharmacology. 1996;47(1):177-185.
Piotrowski J, Slomiany A, Slomiany BL. Inhibition of Helicobacter pylori urease activity by ebrotidine. Biochemistry and molecular biology international. 1995;37(2):247-253.
Mauch F, Bode G, Ditschuneit H, et al. Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology. 1993;105(6):1698-1704. doi: 10.1016/0016-5085(93)91065-p.
Smith AW, Chahal B, French GL. The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Molecular Microbiology. 1994;13(1):153-160. doi: 10.1111/j.1365-2958.1994.tb00410.x.
Cover TL, Halter SA, et al. Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. Human pathology. 1992;23(9):1004-1010. doi: 10.1016/0046-8177(92)90261-z.
Czajkowsky DM, Iwamoto H, Cover TL, et al. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH Proceedings of the National Academy of Sciences of the United States of America. 1999;96(5):2001-2006. doi: 10.1073/pnas.96.5.2001
Gangwer KA, Shaffer CL, Suerbaum Set al. Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA. Journal of bacteriology. 2010;192(23):6126-6135. doi: 10.1128/JB.01081-10.
Cover TL. Helicobacter pylori Diversity and Gastric Cancer Risk. mBio. 2016 ;7(1):e01869-186915. doi: 10.1128/mBio.01869-15.
Davies GR, Banatvala N, Collins CE, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scandinavian journal of gastroenterology. 199;29(5):419-424. doi: 10.3109/00365529409096832.
Gisbert JP, Pajares JM. Helicobacter pylori test-and-treat' strategy for dyspeptic patients. Scandinavian journal of gastroenterology. 1999;34(7):644-652. doi: 10.1080/003655299750025822.
Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. The American journal of gastroenterology. 1998;93(12):2330-2338. doi: 10.1111/j.1572-0241.1998.00684.x.
Kelly SM, Pitcher MC, Farmery SM, et al. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology. 1994;107(6):1671-1674. doi: 10.1016/0016-5085(94)90806-0.
Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. The American journal of gastroenterology. 2006;101(8):1921-30. doi: 10.1111/j.1572-0241.2006.00668.x.
Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61(5):646-664. doi: 10.1136/gutjnl-2012-302084.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365-388. doi: 10.1055/a-0859-1883.
Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointestinal endoscopy, 1994;40(3):342-345. doi: 10.1016/s0016-5107(94)70067-2.
Craanen ME, Dekker W, Blok P, et al. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992;33(1):16-20. doi: 10.1136/gut.33.1.16.
Price AB. The Sydney System: histological division. Journal of gastroenterology and hepatology. 1991;6(3):209-222. doi: 10.1111/j.1440-1746.1991.tb01468.x.
Torun C, Yavuz A, Akan K, et al. Comparison of the diagnostic accuracy of the updated Sydney system and single biopsy. Saudi Journal of Gastroenterology. 2022;28(6):441-447. doi: 10.4103/sjg.sjg_146_22.
Gatta L, Vakil N, Ricci C, et al. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. The American journal of gastroenterology. 2004 ;99(5):823-829. doi: 10.1111/j.1572-0241.2004.30162.x.
Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical microbiology reviews. 2007;20(2):280-322. doi: 10.1128/CMR.00033-06.
Osato MS, Reddy R, Reddy SG, et al. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Archives of internal medicine. 2001;161(9):1217-1220. doi: 10.1001/archinte.161.9.1217.
Sayfalar
1-14
Gelecek
23 Nisan 2024
Telif Hakkı (c) 2024 Akademisyen Yayınevi Kitap Portalı
Lisans
LisansNasıl Atıf Yapılır
1.
Torun C. Epidemiology, Microbiology and Diagnosis of Helicobacter Pylori. Içinde: Kadiroğlu AK, editör. General Internal Medicine VI (Spring) [Internet]. Türkiye: Akademisyen Yayınevi Kitap DOI Portalı; 2024 [a.yer 13 Temmuz 2026]. ss. 1-14. Erişim adresi: https://www.omp35.books.akademisyen.net/index.php/akya/catalog/book/3053/chapter/13725
